Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $731.09 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $152.06 | 9 | $0 (2024) |
| Averitas Pharma Inc. | $116.07 | 4 | $0 (2024) |
| Nevro Corp. | $108.42 | 4 | $0 (2023) |
| Corcept Therapeutics | $89.05 | 4 | $0 (2023) |
| Novo Nordisk Inc | $32.57 | 2 | $0 (2024) |
| Dexcom, Inc. | $31.19 | 2 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $28.10 | 2 | $0 (2021) |
| Azurity Pharmaceuticals, Inc. | $26.55 | 2 | $0 (2023) |
| Lilly USA, LLC | $22.37 | 1 | $0 (2021) |
| Medtronic, Inc. | $19.82 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $241.52 | 11 | Averitas Pharma Inc. ($116.07) |
| 2023 | $261.65 | 14 | Corcept Therapeutics ($89.05) |
| 2022 | $152.74 | 8 | Nevro Corp. ($80.29) |
| 2021 | $75.18 | 5 | ARBOR PHARMACEUTICALS, INC. ($28.10) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $35.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Gastroenterology | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Gastroenterology | ||||||
| 03/19/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Gastroenterology | ||||||
| 12/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Gastroenterology | ||||||
| 10/05/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: PAIN | ||||||
| 09/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Gastroenterology | ||||||
| 06/28/2023 | INTERNATIONAL REHABILITATIVE SCIENCES, INC | RS 4i Plus Sequential Stimulator (Device) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: DME | ||||||
| 06/27/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: Sleep | ||||||
| 06/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Gastroenterology | ||||||
| 05/17/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Endocrinology | ||||||
| 04/12/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/05/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: Sleep | ||||||
| 03/29/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/07/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Endocrinology | ||||||
| 02/15/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Endocrinology | ||||||
| 01/26/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 351 | 939 | $120,895 | $47,050 |
| 2022 | 7 | 318 | 863 | $118,426 | $46,466 |
| 2021 | 6 | 213 | 295 | $34,818 | $16,459 |
| 2020 | 6 | 160 | 225 | $45,809 | $9,333 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 418 | $76,076 | $31,573 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 131 | $17,423 | $6,593 | 37.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 37 | 58 | $10,042 | $2,464 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $4,335 | $1,847 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,572 | $1,467 | 32.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 32 | 42 | $4,200 | $1,235 | 29.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 52 | 229 | $2,290 | $1,133 | 49.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,837 | $648.63 | 35.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 15 | $120.00 | $89.19 | 74.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 455 | $80,606 | $32,616 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 89 | $11,589 | $4,661 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 34 | $8,621 | $3,704 | 43.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 38 | 56 | $9,815 | $2,324 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,045 | $1,633 | 40.4% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 44 | 195 | $1,950 | $950.98 | 48.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 16 | 18 | $1,800 | $577.97 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 105 | $16,353 | $8,612 | 52.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 75 | $7,897 | $4,277 | 54.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,264 | $1,879 | 44.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 19 | 25 | $4,122 | $1,075 | 26.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 18 | 55 | $550.00 | $333.49 | 60.6% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2021 | 17 | 17 | $1,632 | $282.26 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 58 | $9,474 | $3,639 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 73 | $8,271 | $3,183 | 38.5% |
| 22853 | Insertion of device into intervertebral disc space of spine and fusion of vertebrae | Facility | 2020 | 17 | 30 | $21,000 | $857.77 | 4.1% |
About Aaron Reich, PA-C
Aaron Reich, PA-C is a Physician Assistant healthcare provider based in Layton, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1003388265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aaron Reich, PA-C has received a total of $731.09 in payments from pharmaceutical and medical device companies, with $241.52 received in 2024. These payments were reported across 38 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($731.09).
As a Medicare-enrolled provider, Reich has provided services to 1,042 Medicare beneficiaries, totaling 2,322 services with total Medicare billing of $119,309. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Layton, UT
- Active Since 12/27/2018
- Last Updated 08/26/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1003388265
Products in Payments
- RELISTOR (Drug) $152.06
- QUTENZA (Drug) $116.07
- Korlym (Drug) $89.05
- Omnia (Device) $80.29
- Horizant (Drug) $54.65
- Dexcom G6 Transmitter (Medical Supply) $31.19
- Senza (Device) $28.13
- TRULICITY (Drug) $22.37
- OSTEOCOOL RF ABLATION SYSTEM (Device) $19.82
- TZIELD (Biological) $17.65
- SEGLENTIS (Drug) $17.40
- NURTEC ODT (Drug) $17.20
- Ozempic (Drug) $17.13
- Wegovy (Drug) $15.44
- RS 4i Plus Sequential Stimulator (Device) $14.70
- Tymlos (Biological) $13.46
- FARXIGA (Drug) $13.23
- EUFLEXXA (Device) $11.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Layton
Michael Young, Ms, Mpas, Pa-C, MS, MPAS, PA-C
Physician Assistant — Payments: $6,802
Mandi Christensen, P.a, P.A
Physician Assistant — Payments: $5,594
Benjamin Saxey, P.a, P.A
Physician Assistant — Payments: $4,847
Mrs. Melanie Lozano, P.a, P.A
Physician Assistant — Payments: $4,687
Sarah Espinoza
Physician Assistant — Payments: $4,147
Brian Mattsson, Pa-C, PA-C
Physician Assistant — Payments: $3,960